You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Medtronic
Moodys
AstraZeneca

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)

Docket   Start Trial Date Filed 2011-07-25
Court District Court, D. New Jersey Date Terminated 2012-10-15
Cause 35:271 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Douglas E. Arpert
Parties ASTRAZENECA AB; ASTRAZENECA LP; HORIZON PHARMA, INC.; KBI-E INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS INC.; POZEN INC.
Patents 6,875,872; 6,926,907; 7,745,466
Attorneys CARISSA L. RODRIGUE; ELINA SLAVIN; ERICA SUSAN HELMS; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; KAREN A. CONFOY; KRISTEN HEALEY CRAMER; MARK H. ANANIA; SYMONE J. REDWINE
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. LUPIN LTD.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-07-25 1 504 patent will expire on August 3, 2015. 13. United States Patent No. 6,875,872 (“the…5,714,504; 6,875,872; 6,369,085; and 7,411,070. Civil Action No. 09-5404 involves the ’504, ’085, ’872, and… of the ‘504 patent, the ‘872 patent, the ‘085 patent, the ‘070 patent, the ‘466 patent, and the ‘907… The Patents-In-Suit 11. United States Patent No. 5,714,504 (“the ’504 patent”), entitled… This is a civil action for patent infringement arising under the patent laws of the United States, External link to document
2011-09-26 24 Lupin admits that United States Patent No. 6,875,872 (“the ’872 patent”) is entitled “Compounds,” and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and External link to document
2011-10-20 34 that U.S. Patent Nos. 5,714,504 (“the ’504 patent”), 6,369,085 (“the ’085 patent”), 6,875,872 (“the ’872…’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent,’907 patent, and the ‘424 patent, but…the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent,’907 patent, and ’424 patent, and Plaintiffs…of the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent, and ’907 patent. The remaining… of the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent, and ’907 patent and deny the External link to document
2012-07-18 48 infringement of U.S. Patent Nos. 5,7]4,504 (“the ’504 patent”); 6,875,872 (“the ’872 patent”); 6,369,085 (“…(“the ’085 patent”); 7,41 l.,070 (“the ’070 patent”); 7,745,466 (“the ’466 patent”); and 6,926,907 (“the…“the ‘907 patent”) (collectively, “the Asserted Patents”) based on Lupin’s filing of Abbreviated New Drug…non-infringement and invalidity of U.S. Patent No. 5,900,424 (“the ’424 patent”). [D.l. 24.]; WHEREAS in order… ’424 patent are dismissed with prejudice pursuant to Fed. R. Civ. P. 4l.(a)(2). The ’424 patent is presumed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Harvard Business School
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.